The effects of inhalational anesthetics or intravenous anesthetics on rocuronium in children receiving chronic anticonvalsant therapy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0000953

Enrollment

Registered

2013-12-12

Start date

2013-07-15

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : muscle relaxant every T1>25%_muscle relaxant administration 100 ug/kg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: children with antiepileptics more than 7 days

Exclusion criteria

Exclusion criteria: muscle disease previous muscle relaxant side effect history

Design outcomes

Primary

Measure	Time frame
time from recovery to T1>25%	—

Secondary

Measure	Time frame
total dose of muscle relaxant	—

Countries

Korea, Republic of

Contacts

Public ContactKim Hee-soo

Seoul National University Hospital

heejeong895@gmail.com+82-2-2072-3659

Outcome results